Product Program year 2025 Source: CMS Open Payments

VIABAHN Endoprosthesis with PROPATEN Bioactive Surface

Device Devices

Open in the dashboard

General payments

$480,715

1,332 payments

Research payments

$0

0 payments

Through program year 2025, $480,715 in general payments and $0 in research payments were reported against VIABAHN Endoprosthesis with PROPATEN Bioactive Surface (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $131,281 179
2024 General $128,638 174
2023 General $124,306 259
2022 General $46,970 153
2021 General $9,718 175
2020 General $14,758 137
2019 General $25,044 255

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $480,715 1,332 payments
Top recipients General payments · program year 2025
  1. Darren Schneider Vascular Surgery · Philadelphia, PA $19,500 15% · 2 payments
  2. Richard Neville Vascular Surgery · Falls Church, VA $19,500 15% · 2 payments
  3. Venita Chandra Vascular Surgery · Palo Alto, CA $16,404 12% · 2 payments
  4. Steven Abramowitz Vascular Surgery · Washington, DC $13,200 10% · 2 payments
  5. Evan Brownie Vascular Surgery · Murray, UT $10,500 8% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $96,840 74% · 68 practitioners
  2. Interventional Cardiology Internal Medicine $11,523 9% · 6 practitioners
  3. Diagnostic Radiology Radiology $10,750 8% · 5 practitioners
  4. Vascular & Interventional Radiology Radiology $5,179 4% · 7 practitioners
  5. Nephrology Internal Medicine $3,856 3% · 5 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $25,030 19% · 7 recipients
  2. Florida $20,374 16% · 12 recipients
  3. Virginia $19,540 15% · 2 recipients
  4. California $16,639 13% · 7 recipients
  5. District of Columbia $13,200 10% · 1 recipient

The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,332 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record